Tag: anna_stove
-
Rua Bioscience Reports 53% Revenue Growth but Warns Working Capital Is "Immediate Constraint"
Rua Bioscience posts $2.9m total revenue, up 53%, and a narrowing operating loss at its 2026 annual meeting, but says funding inventory for its $10m-plus UK Curaleaf deal is now its biggest challenge.
BusinessHealthUnited KingdomCanadaEconomyFinancial MarketsMedical ScienceTradeEurope Rua BioscienceAnna StovePaul Naskemedicinal cannabisCuraleafannual shareholders meeting
-
Rua Bioscience Rights Offer Raises About $1.0 Million, Short of $2.8 Million Target
Rua Bioscience's 1 for 3 renounceable Rights Offer closed on 15 October 2026, raising roughly $1.0 million from existing shareholders — below the $2.8 million sought and short of working capital needs.
BusinessFinancial MarketsEconomyTrade Rua BioscienceRights OfferNZXAnna Stovecapital raiseUK sales and distribution agreementGisborne manufacturing facility